Literature DB >> 8091322

Comparison of circadian variations using FEV1 and peak expiratory flow rates among normal and asthmatic subjects.

S Troyanov1, H Ghezzo, A Cartier, J L Malo.   

Abstract

BACKGROUND: Most studies that describe circadian variations in asthma have used maximum rate of peak expiratory flow (PEF) rather than forced expiratory volume in one second (FEV1) to assess airway calibre. This study was designed to assess circadian variations in PEF and FEV1 measured simultaneously and to compare variations in these measurements in normal and asthmatic subjects in a stable clinical state.
METHODS: Twenty nine subjects (nine asthmatic subjects on bronchodilators, 10 on inhaled steroids, and 10 normal controls) were asked to record their PEF and FEV1 with a new portable instrument every two hours during the day and once on waking at night for two weeks. Circadian variations were examined in different ways using arithmetical indices and cosinor analysis.
RESULTS: 78% of PEF values and 75% of FEV1 values were considered to be reproducible and were included in the analysis. Variations obtained using PEF did not differ from those obtained using FEV1. Significant cosinor variations were found in at least 50% of recording days for most of the subjects and showed the same features as for arithmetical indices. Daily variations in PEF and FEV1 were significantly correlated with airway calibre and PC20 methacholine (r approximately 0.5 to approximately 0.6).
CONCLUSIONS: PEF is as satisfactory as FEV1 for describing circadian variations among normal subjects and stable asthmatic subjects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8091322      PMCID: PMC475122          DOI: 10.1136/thx.49.8.775

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  25 in total

1.  Comparison of peak expiratory flow rate and FEV1 in assessing bronchomotor tone after challenges with occupational sensitizers.

Authors:  D Bérubé; A Cartier; J L'Archevêque; H Ghezzo; J L Malo
Journal:  Chest       Date:  1991-04       Impact factor: 9.410

2.  Factors related to the nocturnal worsening of asthma.

Authors:  R J Martin; L C Cicutto; R D Ballard
Journal:  Am Rev Respir Dis       Date:  1990-01

3.  An assessment of peak expiratory flow as a surrogate measurement of FEV1 in stable asthmatic children.

Authors:  A A Meltzer; M H Smolensky; G E D'Alonzo; R B Harrist; P H Scott
Journal:  Chest       Date:  1989-08       Impact factor: 9.410

Review 4.  Chronobiology and asthma. I. Day-night differences in bronchial patency and dyspnea and circadian rhythm dependencies.

Authors:  M H Smolensky; P J Barnes; A Reinberg; J P McGovern
Journal:  J Asthma       Date:  1986       Impact factor: 2.515

5.  Monitoring of peak expiratory flow rates in subjects with mild airway hyperexcitability.

Authors:  J Bahous; A Cartier; J L Malo
Journal:  Bull Eur Physiopathol Respir       Date:  1985 Jan-Feb

6.  The distribution of peak expiratory flow variability in a population sample.

Authors:  B G Higgins; J R Britton; S Chinn; T D Jones; D Jenkinson; P G Burney; A E Tattersfield
Journal:  Am Rev Respir Dis       Date:  1989-11

7.  Sir John Floyer's A Treatise of the Asthma (1698).

Authors:  A Sakula
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

8.  Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in a normal population.

Authors:  J L Malo; L Pineau; A Cartier; R R Martin
Journal:  Am Rev Respir Dis       Date:  1983-07

9.  Circadian rhythms.

Authors:  E R McFadden
Journal:  Am J Med       Date:  1988-07-29       Impact factor: 4.965

10.  Variation in peak expiratory flow of normal and asymptomatic asthmatic children.

Authors:  M Albertini; S Politano; E Berard; P Boutte; R Mariani
Journal:  Pediatr Pulmonol       Date:  1989
View more
  9 in total

1.  Quantitative characterization of circadian rhythm of pulmonary function in asthmatic patients treated with inhaled corticosteroids.

Authors:  Di Zhou; Hongshan Li; Yaning Wang; Guenther Hochhaus; Vikram Sinha; Liang Zhao
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-06-23       Impact factor: 2.745

2.  Diurnal Variation in Peak Expiratory Flow and Forced Expiratory Volume.

Authors:  Arun Goel; Manish Goyal; Ruchi Singh; Narsingh Verma; Sunita Tiwari
Journal:  J Clin Diagn Res       Date:  2015-10-01

Review 3.  Breathing around the clock: an overview of the circadian pattern of respiration.

Authors:  Jacopo P Mortola
Journal:  Eur J Appl Physiol       Date:  2003-10-21       Impact factor: 3.078

Review 4.  Outpatient treatment of adult asthma.

Authors:  E C Kleerup; D P Tashkin
Journal:  West J Med       Date:  1995-07

5.  Relationship between sensitivity to dyspnea and fluctuating peak expiratory flow rate in the absence of asthma symptoms.

Authors:  Kuniyoshi Kamiya; Kumiya Sugiyama; Masao Toda; Sayo Soda; Naoya Ikeda; Fumiya Fukushima; Hirokuni Hirata; Yasutsugu Fukushima; Takeshi Fukuda
Journal:  Asia Pac Allergy       Date:  2012-01-31

6.  The effect of the use of NP305 masks in improving respiratory symptoms in workers exposed to sulfuric acid mists in plating and pickling units.

Authors:  Athena Rafieepour; Narges Gholamzadeh Taj Dolatshahi; Alireza Haj Ghasemkhan; Mehdi Asghari; Marzieh Sadeghian; Ali Asadi
Journal:  Electron Physician       Date:  2013-02-01

7.  Assessing the exacerbations risk of influenza-associated chronic occupational asthma.

Authors:  Chung-Min Liao; Nan-Hung Hsieh; Chia-Pin Chio; Szu-Chieh Chen
Journal:  Risk Anal       Date:  2010-04-08       Impact factor: 4.000

8.  The impact of diurnal variation on induced sputum cell counts in healthy adults.

Authors:  Stephanie The; Richard Leigh; Warren J Davidson; Lisa E Wong
Journal:  Clin Transl Allergy       Date:  2013-03-28       Impact factor: 5.871

9.  Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma.

Authors:  Yen Lin Chia; Li Yan; Binbing Yu; Bing Wang; Peter Barker; Mitchell Goldman; Lorin Roskos
Journal:  Clin Pharmacol Ther       Date:  2019-03-22       Impact factor: 6.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.